VYNE THERAPEUTICS INC's ticker is VYNE and the CUSIP is 92941V209. A total of 40 filers reported holding VYNE THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $14,000 | -44.0% | 61,464 | -5.2% | 0.00% | -50.0% |
| Q2 2022 | $25,000 | +56.2% | 64,838 | +163.6% | 0.00% | +100.0% |
| Q1 2022 | $16,000 | -91.1% | 24,601 | -86.0% | 0.00% | -94.4% |
| Q4 2021 | $179,000 | +18.5% | 175,278 | +61.8% | 0.02% | +38.5% |
| Q3 2021 | $151,000 | +62.4% | 108,319 | +696.6% | 0.01% | +85.7% |
| Q1 2021 | $93,000 | – | 13,598 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 400,000 | $2,738,000 | 6.10% |
| DSC Advisors, L.P. | 1,038,145 | $7,106,000 | 4.40% |
| CM Management, LLC | 143,750 | $984,000 | 0.73% |
| Perceptive Advisors | 6,773,954 | $46,368,000 | 0.59% |
| DELTEC ASSET MANAGEMENT LLC | 441,491 | $3,022,000 | 0.45% |
| Perennial Investment Advisors, LLC | 35,000 | $240,000 | 0.10% |
| Tekla Capital Management LLC | 135,395 | $927,000 | 0.03% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 10,051 | $69,000 | 0.02% |
| AXA S.A. | 882,124 | $6,038,000 | 0.02% |
| STALEY CAPITAL ADVISERS INC | 25,000 | $171,000 | 0.01% |